Editas Medicine

Editas Medicine
Genome editing company
Gene Editing
CRISPR Technology
Genomic Medicine
Clinical Research
Rare Diseases
제품 및 서비스

reni-cel
Gene Therapy
ED
EDIT-101
Gene Therapy
ED
EDIT-301
Cell Therapy
CR
CRISPR Gene Editing Platform
Technology Platform
ED
EDIT-201
Gene Therapy

In Vivo Gene Editing Medicines
Gene Therapy
ED
EDIT-103
Gene Therapy
IN
In Vivo Gene Editing Services
R&D Services
CR
CRISPR/Cas Gene Editing Platform
Platform Technology
EX
Ex Vivo Cell Engineering
R&D Services
EX
Ex Vivo Gene Editing Services
Research Services
EN
Engineered Natural Killer (eNK) Cell Platform
Cell Therapy
ED
EDIT-401
Gene Therapy
리더십
CS
Charlene Stern
Executive Vice President & General Counsel
KB
Kevin Bitterman
Interim President
DRL
David R. Liu
Founder
FZ
Feng Zhang
Founder
유사 기업

BioNTech
Develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Mainz, Germany
1,001-5,000명
상장
기업가치 $21.7B
196개 채용공고

Regeneron
Focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations int...
Westchester County, New York
10,001+명
상장
기업가치 $76B
559개 채용공고

Exact Sciences
Cancer screening and diagnostics
Madison, Wisconsin, United States
5,001-10,000명
상장
기업가치 $3.2B
239개 채용공고

CRISPR Therapeutics
Leading company in the technology industry
Cambridge, Massachusetts, United States
201-500명
상장
기업가치 $2.9B
14개 채용공고

Boston Scientific
Leading company in the technology industry
Marlborough, Massachusetts
10,001+명
상장
기업가치 $58B
1,004개 채용공고
최근 소식
All
X
News
HN
YouTube
Editas Medicine shares edge higher after Q4 earnings and revenue top estimates - MSN
MSN
News
·
1개월 전
Attachment - GlobeNewswire
GlobeNewswire
News
·
1개월 전
Editas Medicine (NASDAQ:EDIT) Share Price Passes Above 50 Day Moving Average - Here's What Happened - MarketBeat
MarketBeat
News
·
1개월 전
Evercore Maintains Editas Medicine(EDIT.US) With Buy Rating, Raises Target Price to $15 - 富途牛牛
富途牛牛
News
·
1개월 전
Editas Medicine price target raised to $15 from $13 at Evercore ISI - TipRanks
TipRanks
News
·
1개월 전
더 보기 (15개 남음)
전체 조회수
0
전체 지원 클릭
0
전체 Mock Apply
0
전체 스크랩
0
리뷰
4.2
5개 리뷰
워라밸
4.0
보상
3.5
문화
4.3
커리어
2.8
경영진
3.5
78%
지인 추천률
장점
Supportive and collaborative team environment
Great work-life balance and flexible hours
Cutting-edge research opportunities
단점
Limited career advancement opportunities
High expectations and stress levels
Disorganized management practices
연봉 정보
38개 데이터
Director
Junior/L3
Director
1개 리포트
$195,000
총 연봉
기본급
$150,000
주식
-
$195,000
$195,000
면접 후기
후기 39개
난이도
3.4
/ 5
소요 기간
2-5w
합격률
35%
경험
긍정 67%
보통 15%
부정 18%
면접 과정
1
Phone Screen
2
Technical Interview
3
Hiring Manager
4
Team Fit
연락처 및 위치